ADBiotech Co., Ltd. (KOSDAQ:179530)

ADBiotech Revenue

ADBiotech had revenue of 3.07B KRW in the quarter ending March 31, 2026, a decrease of -11.13%. This brings the company's revenue in the last twelve months to 12.51B, up 1.74% year-over-year. In the year 2025, ADBiotech had annual revenue of 12.90B with 15.81% growth.

• Revenue (ttm): 12.51B
• Revenue Growth: +1.74%
• P/S Ratio: 4.93
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 61.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	12.90B	1.76B	15.81%
Dec 31, 2024	11.14B	664.30M	6.34%
Dec 31, 2023	10.47B	-159.63M	-1.50%
Dec 31, 2022	10.63B	-1.21B	-10.21%
Dec 31, 2021	11.84B	2.02B	20.63%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 25, 2026

Data Sources Report a data error